Endophthalmitis after intravitreal injection: Decreasing incidence and clinical outcome - 8-year results from a tertiary ophthalmic referral center

Retina

Volumn 34, Issue 5, 2014, Pages 943-950

  Nentwich, Martin M ^a   Yactayo Miranda, Yazmin ^a   Schwarzbach, Fabian ^a   Wolf, Armin ^a   Kampik, Anselm ^a   Mino De Kaspar, Herminia ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Endophthalmitis; Intravitreal injection; Povidone iodine; Prophylaxis

Indexed keywords

ALTEPLASE; BEVACIZUMAB; DEXAMETHASONE; METHOTREXATE; PEGAPTANIB; RANIBIZUMAB; SULFUR HEXAFLUORIDE; TRIAMCINOLONE ACETONIDE; ANGIOGENESIS INHIBITOR; POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; GERMANY; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OPERATING ROOM; OUTCOME ASSESSMENT; RETINA DETACHMENT; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; VERY ELDERLY; VISUAL ACUITY; EPIDEMIOLOGY; EYE INFECTIONS, BACTERIAL; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATIENT REFERRAL; PHYSIOLOGY; RETINAL DISEASES; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFECTIVE AGENTS, LOCAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; GERMANY; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; POVIDONE-IODINE; REFERRAL AND CONSULTATION; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTERS; VISUAL ACUITY;

EID: 84899935772     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000011     Document Type: Article

References (28)

1. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29:875-912.
2. McCannel CA. Meta-Analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011;31:654-661.
3. Lyall DA, Tey A, Foot B, et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 2012;26:1517-1526.
4. Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina 2011;31:2032-2036.
5. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3.
6. Jaissle GB, Szurman P, Bartz-Schmidt KU. Recommendation for the implementation of intravitreal injections-statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monbl Augenheilkd 2005;222:390.
7. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-1775.
8. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009;116:1498-1501.
9. Hasenfratz G. Echographic findings with standardized echography in acute endophthalmitis. Fortschr Ophthalmol 1987;84:255-257.
10. Goldberg RA, Flynn HW Jr, Isom RF, et al. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 2012;153:204-208 e1.
11. Goldberg RA, Flynn HW Jr, Miller D, et al. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Ophthalmology 2013;120:1448-1453.
12. Cheung CS, Wong AW, Lui A, et al. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 2012;119:1609-1614.
13. Abell RG, Kerr NM, Allen P, Vote BJ. Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol 2012;96: 1474-1478.
14. Tao Y, Jonas JB. Intravitreal triamcinolone. Ophthalmologica 2011;225:1-20.
15. Nentwich M, Yactayo-Miranda Y, Weimann S, et al. Bacterial contamination of needle points after intravitreal injection. Eur J Ophthalmol 2009;19:268-272.
16. Gines JC, Nentwich MM, Peggy Bedoya AH, et al. Bacterial contamination of needles after intravitreal injection in Paraguay. Ophthalmologe 2012;109:782-787.
17. Nentwich MM, Rajab M, Ta CN, et al. Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery. Eur J Ophthalmol 2012;22:541-546.
18. Li B, Nentwich MM, Hoffmann LE, et al. Povidone-Iodine 1. 0%, 5. 0%, and 10. 0% as preoperative prophylaxis before cataract surgery. J Cataract Refract Surg 2013;39:994-1001.
19. Friedman DA,Mason JO 3rd, Emond T, McGwin G Jr. Povidoneiodine contact time and lid speculum use during intravitreal injection. Retina 2013;33:975-981.
20. Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 2012;96:862-866.
21. Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina 2011;31:1525-1533.
22. Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 2012;32:473-476.
23. Hoevenaars NE, Gans D, Missotten T, et al. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review. Ophthalmologica 2012;228;143-147.
24. Mezad-Koursh D, Goldstein M, Heilwail G, et al. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor. Retina 2010;30: 1051-1057.
25. Bhavsar AR, Stockdale CR, Ferris FL 3rd, et al. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol 2012;130:809-810.
26. Bhavsar AR, Ip MS, Glassman AR; Drcrnet, the SSG. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 2007;144:454-456.
27. Bhavsar AR, Googe JM Jr, Stockdale CR, et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol 2009;127:1581-1583.
28. Meyer CH, Mennel S, Eter N. Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application. Ophthalmologe 2007;104: 952-957.